Cargando…
What’s new in molecular genetic pathology 2022: immune checkpoint inhibitor biomarkers and select solid tumors
Predictive biomarker testing plays a critical role in targeted immuno-oncology, including the use of immune checkpoint inhibitors (ICI) for various solid tumors. Molecular advancements in cancers of the breast, kidney and brain have continued to propel tumor classification and precision therapy.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934997/ https://www.ncbi.nlm.nih.gov/pubmed/35306778 http://dx.doi.org/10.4132/jptm.2022.01.25 |